- Home
- Johnson & Johnson
Johnson & Johnson
Can an Apple Watch reduce the likelihood of suffering a stroke? The innovative study that’s tackling the problem of AFib
Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.
Could the answer to preventing hospital-acquired pneumonia be as simple as better oral care? This nurse thinks so.
Some 157,000 patients are diagnosed with the condition each year. But trailblazing nurse Dian Baker has a straightforward yet innovative solution.
An expert explains the latest good—yes, good!—news about lung cancer
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what’s to come in better detecting and preventing it.
The charming way Johnson & Johnson showed its thanks to employees in the 1960s
We posed a question to Johnson & Johnson’s Chief Historian: What artifact from the archives do you love best?
That’s so presidential! 4 of Johnson & Johnson’s most memorable moments with heads of state
In honor of Presidents’ Day, the company’s chief historian shares some stories of special company connections to former U.S. presidents, including the day one leader awarded Johnson & Johnson with a medal for a century’s worth of innovation.
What you need to know about the coronavirus—and a potential preventive vaccine
The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.
From actor to advocate: A new MTV star opens up about the TB epidemic
When Syed Raza Ahmed took a role playing a 20-something living with TB, he knew he had a responsibility to educate others and help reduce stigma. As his MTV show debuts, he sat down with us to reveal what he’s learned about the world’s deadliest infectious disease.
What you need to know about Johnson & Johnson’s 2019 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.
Alzheimer’s disease: Why one company refuses to give up the search for a cure
It’s the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
Johnson & Johnson pledges $600,000 in disaster relief in response to the bushfire crisis in Australia
It’s just one way the company has mobilized to help the country with both emergency and recovery efforts in the wake of the large-scale fires.